With the first DCB market introduction the founder of Cardionovum contributed significantly to the establishment of a new medical device therapy to treat coronary and peripheral artery disease effectively. The treatment of coronary stent-associated patient problems, like in-stent restenosis (ISR), and the treatment of peripheral artery lesions by a DCB have become the preferred treatment standard.